Company Directory / research
PrivateFor profitresearchMinato, Japan
Restore Vision
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.
- Founded
- 2016 10 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $2.5B as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
10 years old.
Reach
No web traffic ranking listed.
What it does
BiotechnologyHealth CareTherapeutics
Funding, as listed
$2.5B currency not stated
- Rounds4
- LatestSeries a, Dec 2023
- Investors13, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Restore Vision, field by field. Contact details are held but never shown.
The company
- Name
- Restore Vision
- Type
- For profit
- Status
- Private
- Founded
- 2016
- Industry
- research
- Categories
- Biotechnology, Health Care, Therapeutics
Where
- City
- Minato
- Country
- Japan
- Markets
- Asia-Pacific (APAC)
Size and reach
- Staff band
- 1-10
Funding, as listed
- Total
- 2,470,000,000 (currency not stated)
- Rounds
- 4
- Latest round
- Series a
- Latest round date
- Dec 2023
- Investors
- 13
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Restore Vision may be growing as indicated by the context of the news articles. The global retinal implant market, which is relevant to Restore Vision's field, is anticipated to reach $112.2 million by 2030, suggesting a growing market for their visual restoration therapies. Additionally, advancements in stem cell research for retinal degeneration and the development of bionic eye technology align with the company's focus on gene therapy for retinitis pigmentosa, indicating a positive trend in the industry that could benefit Restore Vision. Furthermore, the mention of new treatments for retinal diseases and the pursuit of gene therapies for rare inherited diseases reflect a dynamic and expanding sector that Restore Vision is a part of.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Japan.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 32,492 companies in Japan and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.